CIBC Private Wealth Group LLC Reduces Stake in PRA Health Sciences Inc (PRAH)

CIBC Private Wealth Group LLC reduced its position in PRA Health Sciences Inc (NASDAQ:PRAH) by 0.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 176,032 shares of the medical research company’s stock after selling 787 shares during the period. CIBC Private Wealth Group LLC owned approximately 0.27% of PRA Health Sciences worth $16,187,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently added to or reduced their stakes in the company. Frontier Capital Management Co. LLC bought a new position in PRA Health Sciences in the 3rd quarter worth $78,126,000. Thrivent Financial for Lutherans raised its holdings in PRA Health Sciences by 20.6% in the 3rd quarter. Thrivent Financial for Lutherans now owns 13,907 shares of the medical research company’s stock worth $1,532,000 after purchasing an additional 2,373 shares during the period. Texas Permanent School Fund raised its holdings in PRA Health Sciences by 13.9% in the 3rd quarter. Texas Permanent School Fund now owns 36,452 shares of the medical research company’s stock worth $4,017,000 after purchasing an additional 4,456 shares during the period. First National Bank of Hutchinson raised its holdings in PRA Health Sciences by 34.8% in the 3rd quarter. First National Bank of Hutchinson now owns 9,690 shares of the medical research company’s stock worth $1,068,000 after purchasing an additional 2,501 shares during the period. Finally, GAM Holding AG raised its holdings in PRA Health Sciences by 24.5% in the 3rd quarter. GAM Holding AG now owns 5,694 shares of the medical research company’s stock worth $627,000 after purchasing an additional 1,121 shares during the period. Hedge funds and other institutional investors own 98.14% of the company’s stock.

NASDAQ:PRAH opened at $110.98 on Wednesday. The company has a current ratio of 0.89, a quick ratio of 0.89 and a debt-to-equity ratio of 1.22. The stock has a market cap of $6.97 billion, a price-to-earnings ratio of 34.68, a price-to-earnings-growth ratio of 1.33 and a beta of 1.14. PRA Health Sciences Inc has a 52 week low of $79.20 and a 52 week high of $121.98.

A number of equities research analysts have commented on the company. BidaskClub raised PRA Health Sciences from a “buy” rating to a “strong-buy” rating in a report on Thursday, November 8th. ValuEngine cut PRA Health Sciences from a “buy” rating to a “hold” rating in a report on Wednesday, January 2nd. Zacks Investment Research cut PRA Health Sciences from a “buy” rating to a “hold” rating in a report on Wednesday, January 2nd. Finally, SunTrust Banks raised their price target on PRA Health Sciences to $120.00 and gave the company a “buy” rating in a report on Monday, November 5th. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. PRA Health Sciences currently has an average rating of “Buy” and a consensus target price of $112.56.

TRADEMARK VIOLATION WARNING: “CIBC Private Wealth Group LLC Reduces Stake in PRA Health Sciences Inc (PRAH)” was reported by Community Financial News and is owned by of Community Financial News. If you are reading this news story on another publication, it was copied illegally and republished in violation of international copyright law. The original version of this news story can be viewed at https://www.com-unik.info/2019/02/13/cibc-private-wealth-group-llc-reduces-stake-in-pra-health-sciences-inc-prah.html.

About PRA Health Sciences

PRA Health Sciences, Inc, a contract research organization, provides outsourced clinical development services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services.

See Also: Compound Annual Growth Rate (CAGR)

Institutional Ownership by Quarter for PRA Health Sciences (NASDAQ:PRAH)

Receive News & Ratings for PRA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PRA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit